Effectiveness, safety and cost of drug substitution in hypertension
about
Innovative Approaches to Hypertension Control in Low- and Middle-Income Countries.Potential Clinical and Economic Impact of Switching Branded Medications to Generics.Editors' pick 2010.A review of the differences and similarities between generic drugs and their originator counterparts, including economic benefits associated with usage of generic medicines, using Ireland as a case study.Off-label indications for antidepressants in primary care: descriptive study of prescriptions from an indication based electronic prescribing system.Generic medicines and generic substitution: contrasting perspectives of stakeholders in IrelandCluster randomized trials of prescription medicines or prescribing policy: public and general practitioner opinions in ScotlandGeneric substitution of antiepileptic drugs.Improving Adherence to Treatment and Reducing Economic Costs of Hypertension: The Role of Olmesartan-Based Treatment.Blood Pressure Management in Intracranial Hemorrhage: Current Challenges and Opportunities.From NCE to NICE: the role of pharmacoeconomics.[Analysis of the decision to buy medicine in light of the existence of generic products: a study in the city of Belo Horizonte, Brazil].A retrospective analysis of drug-related problems documented in a national database.The Effect of Dongeui Qigong for Prehypertension and Mild Essential Hypertension.Pharmacare: Are we getting the right medicines?Product standardisation as a tool to control prescribing costs - a case study of alginate liquid preparations.
P2860
Q30240646-BB1EFF19-5C7B-4B57-B6EF-BCD5B8F276C3Q33637817-E702E208-2726-4890-BA35-38B57943B84DQ34476042-E515311A-359C-4D12-BE94-D90484450F37Q34536861-11D4A32D-0AC9-42DB-8D8D-2C5AF3F84CA8Q34680866-60C144EC-BCC3-4DD0-8047-5D968CC3EEF3Q35869235-2E590565-83D6-46D2-9671-D60E7F87F173Q36220238-47895784-39EC-4289-90E4-64A5E5414F06Q37810997-E61D0FFB-5D20-41BB-8A10-AC4BCD0B2889Q39427698-0576600A-F22C-436D-8BA7-BF0706089175Q39973169-FB3CE95C-209E-40A4-BCAC-C573370C4A60Q42414047-3740CD62-1A3F-4882-ABBF-5AD2797AC1C5Q43506648-424A59A5-D481-4359-B540-997FEE5CAE88Q45914067-E34DA9E5-D491-4364-9DC7-46C42B16F5F4Q47116105-C100DB7A-B840-4D39-8739-64D181659BB5Q49997264-BD42902D-F249-4BAE-98B1-2C55FFE44DDEQ50105577-F0D22800-E0DE-43F6-B562-DC1B20A8EEA3
P2860
Effectiveness, safety and cost of drug substitution in hypertension
description
2010 nî lūn-bûn
@nan
2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Effectiveness, safety and cost of drug substitution in hypertension
@ast
Effectiveness, safety and cost of drug substitution in hypertension
@en
Effectiveness, safety and cost of drug substitution in hypertension
@nl
type
label
Effectiveness, safety and cost of drug substitution in hypertension
@ast
Effectiveness, safety and cost of drug substitution in hypertension
@en
Effectiveness, safety and cost of drug substitution in hypertension
@nl
prefLabel
Effectiveness, safety and cost of drug substitution in hypertension
@ast
Effectiveness, safety and cost of drug substitution in hypertension
@en
Effectiveness, safety and cost of drug substitution in hypertension
@nl
P2093
P2860
P1476
Effectiveness, safety and cost of drug substitution in hypertension
@en
P2093
Atholl Johnston
George S Stergiou
Panagiotis Stafylas
P2860
P304
P356
10.1111/J.1365-2125.2010.03681.X
P407
P577
2010-09-01T00:00:00Z